Mexico In Vitro Diagnostics Market Outlook to 2016 now available at ReportsandReports

0

Dallas, TX: ReportsandReports announce it Mexico In Vitro Diagnostics Market Outlook to 2016  Market Research Report in its Store.

 

Browse complete Report at http://www.reportsandreports.com/market-reports/mexico-in-vitro-diagnostics-market-outlook-to-2016/

GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Mexico In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
  • 2009 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the Mexico In Vitro Diagnostics (IVD) market.
  • Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Mexico In Vitro Diagnostics (IVD) competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1.1 List of Tables 8
1.2 List of Figures 11

2 Introduction 14
2.1 What is This Report About? 14

3 In Vitro Diagnostics In Mexico 15
3.1 In Vitro Diagnostics, Market Segmentation 15
3.2 In Vitro Diagnostics, Mexico, Overall Revenue ($m), 2002-2016 16
3.3 In Vitro Diagnostics Market, Mexico, Revenue Mix ($m), 2009 18
3.4 In Vitro Diagnostics Market, Mexico, Category Contribution (%), 2009 19
3.5 In Vitro Diagnostics, Mexico, Company Share (2008-2009) 25

4 Clinical Chemistry In Mexico 26
4.1 Clinical Chemistry, Market Segmentation 26
4.2 Clinical Chemistry Market, Mexico, Revenue Mix ($m), 2009 27
4.3 Clinical Chemistry Market, Mexico, Category Contribution (%), 2009 28
4.4 Clinical Chemistry Overall Revenue (2002-2016) 29
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 33
4.4.2 Urine Analysis Revenue (2002-2016) 37
4.5 Clinical Chemistry Distribution Share (2008-2009) 41
4.6 Clinical Chemistry, Mexico, Company Share (2008-2009) 42

5 Genetic Testing In Mexico 44
5.1 Genetic Testing, Market Segmentation 44
5.2 Genetic Testing Market, Mexico, Revenue Mix ($m), 2009 45
5.3 Genetic Testing Market, Mexico, Category Contribution (%), 2009 46
5.4 Genetic Testing Overall Revenue (2002-2016) 47
5.5 Genetic Testing Distribution Share (2008-2009) 51
5.6 Genetic Testing, Mexico, Company Share (2008-2009) 52

6 Haematology In Mexico 54
6.1 Haematology, Market Segmentation 54
6.2 Haematology Market, Mexico, Revenue Mix ($m), 2009 55
6.3 Haematology Market, Mexico, Category Contribution (%), 2009 56
6.4 Haematology Overall Revenue (2002-2016) 57
6.4.1 Haematology Reagents Revenue (2002-2016) 61
6.4.2 Immunohaematology Revenue (2002-2016) 65
6.4.3 Haemostasis Revenue (2002-2016) 69
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 73
6.4.5 Haematology Cell Counters Revenue (2002-2016) 75
6.5 Haematology Distribution Share (2008-2009) 78
6.6 Haematology, Mexico, Company Share (2008-2009) 79

7 Histology And Cytology In Mexico 81
7.1 Histology and Cytology, Market Segmentation 81
7.2 Histology and Cytology Market, Mexico, Revenue Mix ($m), 2009 82
7.3 Histology and Cytology Market, Mexico, Category Contribution (%), 2009 83
7.4 Histology And Cytology Overall Revenue (2002-2016) 84
7.4.1 Histology Revenue (2002-2016) 88
7.5 Histology and Cytology Distribution Share (2008-2009) 92
7.6 Histology And Cytology, Mexico, Company Share (2008-2009) 93

8 Immuno Chemistry In Mexico 95
8.1 Immuno Chemistry, Market Segmentation 95
8.2 Immuno Chemistry Market, Mexico, Revenue Mix ($m), 2009 96
8.3 Immuno Chemistry Market, Mexico, Category Contribution (%), 2009 97
8.4 Immuno Chemistry Overall Revenue (2002-2016) 98
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 102
8.4.2 Drug Related Testing Revenue (2002-2016) 106
8.4.3 Endocrinology Tests Revenue (2002-2016) 109
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 112
8.5 Immuno Chemistry Distribution Share (2008-2009) 116
8.6 Immuno Chemistry, Mexico, Company Share (2008-2009) 117

9 Infectious Immunology In Mexico 119
9.1 Infectious Immunology, Market Segmentation 119
9.2 Infectious Immunology Market, Mexico, Revenue Mix ($m), 2009 120
9.3 Infectious Immunology Market, Mexico, Category Contribution (%), 2009 121
9.4 Infectious Immunology Overall Revenue (2002-2016) 122
9.5 Infectious Immunology Distribution Share (2008-2009) 126
9.6 Infectious Immunology, Mexico, Company Share (2008-2009) 127

10 Microbiology Culture In Mexico 129
10.1 Microbiology Culture, Market Segmentation 129
10.2 Microbiology Culture Market, Mexico, Revenue Mix ($m), 2009 130
10.3 Microbiology Culture Market, Mexico, Category Contribution (%), 2009 131
10.4 Microbiology Culture Overall Revenue (2002-2016) 132
10.4.1 Microbiology Analyzers Revenue (2002-2016) 136
10.5 Microbiology Culture Distribution Share (2008-2009) 140
10.6 Microbiology Culture, Mexico, Company Share (2008-2009) 141

11 Overview of Key Companies in Mexico In Vitro Diagnostics Market 142
11.1 F. Hoffmann-La Roche Ltd. 142
11.1.1 Company Overview 142
11.2 Share in the Mexico In Vitro Diagnostics Market 142
11.3 Abbott Laboratories 143
11.3.1 Company Overview 143
11.3.2 Share in the Mexico In Vitro Diagnostics Market 143
11.4 Siemens Healthcare 144
11.4.1 Company Overview 144
11.4.2 Share in the Mexico In Vitro Diagnostics Market 144
11.5 Beckman Coulter, Inc. 145
11.5.1 Company Overview 145
11.5.2 Share in the Mexico In Vitro Diagnostics Market 145
11.6 bioMerieux S.A. 146
11.6.1 Company Overview 146
11.6.2 Share in the Mexico In Vitro Diagnostics Market 146
11.7 Ortho-Clinical Diagnostics Inc. 147
11.7.1 Company Overview 147
11.7.2 Share in the Mexico In Vitro Diagnostics Market 147
11.8 Inverness Medical Innovations, Inc. 148
11.8.1 Company Overview 148
11.9 Becton, Dickinson and Company 148
11.9.1 Company Overview 148
11.10 Bio-Rad Laboratories, Inc. 149
11.10.1 Company Overview 149
11.11 Hologic, Inc. 149
11.11.1 Company Overview 149
11.12 OLYMPUS CORPORATION 150
11.12.1 Company Overview 150
11.13 Mindray Medical International Limited 150
11.13.1 Company Overview 150
11.14 Sysmex Corporation 151
11.14.1 Company Overview 151
11.15 Ventana Medical Systems, Inc. 151
11.15.1 Company Overview 151
11.16 DiaSorin S.p.A 151
11.16.1 Company Overview 151
11.17 Qiagen N.V. 152
11.17.1 Company Overview 152
11.18 Gen-Probe Incorporated 152
11.18.1 Company Overview 152
11.19 Phadia AB 152
11.19.1 Company Overview 152

12 In Vitro Diagnostics Market Pipeline Products 153
12.1 Clinical Chemisty Market Pipeline Products 153
12.2 Immuno Chemistry Market Pipeline Products 155
12.3 Haematology Market Pipeline Products 156
12.4 Infectious Immunology Market Pipeline Products 157
12.5 Microbiology Culture Market Pipeline Products 159
12.6 Histology and Cytology Market Pipeline Products 160
12.7 Genetic Testing Market Pipeline Products 161

13 Financial Deals Landscape 163
13.1 Partnerships 163
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 163
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 164
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 165
13.1.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 166
13.1.5 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 167

14 Appendix 168
14.1 Definitions of Markets Covered in the Report 169
14.1.1 In Vitro Diagnostics 169
14.2 Research Methodology 176
14.3 Secondary Research 177
14.4 Primary Research 177
14.5 Models 178
14.6 Forecasts 178
14.7 Expert Panels 178
14.8 GlobalData Consulting 178
14.9 Currency Conversion 179
14.10 Contact Us 179
14.11 Disclaimer 179

1.1 List of Tables

Table 1: In Vitro Diagnostics, Mexico, Overall Revenue ($m), 2002-2016 17
Table 2: In Vitro Diagnostics Market, Mexico, Category Contribution (%), 2009 19
Table 3: In Vitro Diagnostics, Mexico, Cross-Category Analysis, 2002-2016 20
Table 4: In Vitro Diagnostics, Mexico, Overall Revenue ($m), Historic, 2002-2009 22
Table 5: In Vitro Diagnostics, Mexico, Overall Revenue ($m), Forecast, 2009-2016 24
Table 6: In Vitro Diagnostics, Mexico, Company Share by Revenue ($m), 2008-2009 25
Table 7: Clinical Chemistry Market, Mexico, Category Contribution (%), 2009 28
Table 8: Clinical Chemistry, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 30
Table 9: Clinical Chemistry, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 32
Table 10: Clinical Chemisty Analyzers, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 34
Table 11: Clinical Chemisty Analyzers, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36
Table 12: Urine Analysis, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Table 13: Urine Analysis, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Table 14: Clinical Chemistry, Mexico, Distribution Share by Revenue ($m), 2008-2009 41
Table 15: Clinical Chemistry, Mexico, Company Share by Revenue ($m), 2008-2009 43
Table 16: Genetic Testing Market, Mexico, Category Contribution (%), 2009 46
Table 17: Genetic Testing, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 48
Table 18: Genetic Testing, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 50
Table 19: Genetic Testing, Mexico, Distribution Share by Revenue ($m), 2008-2009 51
Table 20: Genetic Testing, Mexico, Company Share by Revenue ($m), 2008-2009 53
Table 21: Haematology Market, Mexico, Category Contribution (%), 2009 56
Table 22: Haematology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 58
Table 23: Haematology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 60
Table 24: Haematology Reagents, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Table 25: Haematology Reagents, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Table 26: Immunohaematology, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Table 27: Immunohaematology, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Table 28: Haemostasis, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Table 29: Haemostasis, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Table 30: Haematology Rapid Tests, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 73
Table 31: Haematology Rapid Tests, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 74
Table 32: Haematology Cell Counters, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75
Table 33: Haematology Cell Counters, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77
Table 34: Haematology, Mexico, Distribution Share by Revenue ($m), 2008-2009 78
Table 35: Haematology, Mexico, Company Share by Revenue ($m), 2008-2009 80
Table 36: Histology and Cytology Market, Mexico, Category Contribution (%), 2009 83
Table 37: Histology And Cytology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 85
Table 38: Histology And Cytology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 87
Table 39: Histology, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 89
Table 40: Histology, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 91
Table 41: Histology And Cytology, Mexico, Distribution Share by Revenue ($m), 2008-2009 92
Table 42: Histology And Cytology, Mexico, Company Share by Revenue ($m), 2008-2009 94
Table 43: Immuno Chemistry Market, Mexico, Category Contribution (%), 2009 97
Table 44: Immuno Chemistry, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 99
Table 45: Immuno Chemistry, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 101
Table 46: Disease Specific Immunochemistry, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 103
Table 47: Disease Specific Immunochemistry, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 105
Table 48: Drug Related Testing, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Table 49: Drug Related Testing, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Table 50: Endocrinology Tests, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109
Table 51: Endocrinology Tests, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 111
Table 52: Immunochemistry Analyzers, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 113
Table 53: Immunochemistry Analyzers, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 115
Table 54: Immuno Chemistry, Mexico, Distribution Share by Revenue ($m), 2008-2009 116
Table 55: Immuno Chemistry, Mexico, Company Share by Revenue ($m), 2008-2009 118
Table 56: Infectious Immunology Market, Mexico, Category Contribution (%), 2009 121
Table 57: Infectious Immunology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 123
Table 58: Infectious Immunology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 125
Table 59: Infectious Immunology, Mexico, Distribution Share by Revenue ($m), 2008-2009 126
Table 60: Infectious Immunology, Mexico, Company Share by Revenue ($m), 2008-2009 128
Table 61: Microbiology Culture Market, Mexico, Category Contribution (%), 2009 131
Table 62: Microbiology Culture, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 133
Table 63: Microbiology Culture, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 135
Table 64: Microbiology Analyzers, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 137
Table 65: Microbiology Analyzers, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 139
Table 66: Microbiology Culture, Mexico, Distribution Share by Revenue ($m), 2008-2009 140
Table 67: Microbiology Culture, Mexico, Company Share by Revenue ($m), 2008-2009 141
Table 68: Clinical Chemisty Market Pipeline Products 153
Table 69: Immuno Chemistry Market Pipeline Products 155
Table 70: Haematology Market Pipeline Products 156
Table 71: Infectious Immunology Market Pipeline Products 157
Table 72: Microbiology Culture Market Pipeline Products 159
Table 73: Histology and Cytology Market Pipeline Products 160
Table 74: Genetic Testing Market Pipeline Products 161
Table 75: QIAGEN Enters Into Distribution Agreement With Celera 163
Table 76: Sequenom Enters Into Licensing Agreement With Optherion 164
Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 165
Table 78: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 166
Table 79: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 167
Table 80: USD to Local Currency, Mexico, Average Actual Rate 2002-2009 179

1.2 List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 15
Figure 2: In Vitro Diagnostics, Mexico, Overall Revenue ($m), 2002-2016 16
Figure 3: In Vitro Diagnostics Market, Mexico, Revenue Mix ($m), 2009 18
Figure 4: In Vitro Diagnostics Market, Mexico, Category Contribution (%), 2009 19
Figure 5: In Vitro Diagnostics, Mexico, Cross-Category Analysis, 2002-2016 20
Figure 6: In Vitro Diagnostics, Mexico, Overall Revenue ($m), Historic, 2002-2009 21
Figure 7: In Vitro Diagnostics, Mexico, Overall Revenue ($m), Forecast, 2009-2016 23
Figure 8: In Vitro Diagnostics, Mexico, Company Share (%), 2009 25
Figure 9: Clinical Chemistry, Market Segmentation 26
Figure 10: Clinical Chemistry Market, Mexico, Revenue Mix ($m), 2009 27
Figure 11: Clinical Chemistry Market, Mexico, Category Contribution (%), 2009 28
Figure 12: Clinical Chemistry, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 29
Figure 13: Clinical Chemistry, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 31
Figure 14: Clinical Chemisty Analyzers, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 33
Figure 15: Clinical Chemisty Analyzers, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 35
Figure 16: Urine Analysis, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 37
Figure 17: Urine Analysis, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Figure 18: Clinical Chemistry, Mexico, Company Share (%), 2009 42
Figure 19: Genetic Testing, Market Segmentation 44
Figure 20: Genetic Testing Market, Mexico, Revenue Mix ($m), 2009 45
Figure 21: Genetic Testing Market, Mexico, Category Contribution (%), 2009 46
Figure 22: Genetic Testing, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 47
Figure 23: Genetic Testing, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 49
Figure 24: Genetic Testing, Mexico, Company Share (%), 2009 52
Figure 25: Haematology, Market Segmentation 54
Figure 26: Haematology Market, Mexico, Revenue Mix ($m), 2009 55
Figure 27: Haematology Market, Mexico, Category Contribution (%), 2009 56
Figure 28: Haematology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 57
Figure 29: Haematology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 59
Figure 30: Haematology Reagents, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 61
Figure 31: Haematology Reagents, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 63
Figure 32: Immunohaematology, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65
Figure 33: Immunohaematology, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 67
Figure 34: Haemostasis, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 69
Figure 35: Haemostasis, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 71
Figure 36: Haematology Rapid Tests, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 73
Figure 37: Haematology Rapid Tests, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 74
Figure 38: Haematology Cell Counters, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75
Figure 39: Haematology Cell Counters, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76
Figure 40: Haematology, Mexico, Company Share (%), 2009 79
Figure 41: Histology and Cytology, Market Segmentation 81
Figure 42: Histology and Cytology Market, Mexico, Revenue Mix ($m), 2009 82
Figure 43: Histology and Cytology Market, Mexico, Category Contribution (%), 2009 83
Figure 44: Histology And Cytology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 84
Figure 45: Histology And Cytology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 86
Figure 46: Histology, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 88
Figure 47: Histology, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 90
Figure 48: Histology And Cytology, Mexico, Company Share (%), 2009 93
Figure 49: Immuno Chemistry, Market Segmentation 95
Figure 50: Immuno Chemistry Market, Mexico, Revenue Mix ($m), 2009 96
Figure 51: Immuno Chemistry Market, Mexico, Category Contribution (%), 2009 97
Figure 52: Immuno Chemistry, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 98
Figure 53: Immuno Chemistry, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 100
Figure 54: Disease Specific Immunochemistry, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 102
Figure 55: Disease Specific Immunochemistry, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 104
Figure 56: Drug Related Testing, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Figure 57: Drug Related Testing, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 107
Figure 58: Endocrinology Tests, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109
Figure 59: Endocrinology Tests, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 110
Figure 60: Immunochemistry Analyzers, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 112
Figure 61: Immunochemistry Analyzers, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 114
Figure 62: Immuno Chemistry, Mexico, Company Share (%), 2009 117
Figure 63: Infectious Immunology, Market Segmentation 119
Figure 64: Infectious Immunology Market, Mexico, Revenue Mix ($m), 2009 120
Figure 65: Infectious Immunology Market, Mexico, Category Contribution (%), 2009 121
Figure 66: Infectious Immunology, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 122
Figure 67: Infectious Immunology, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 124
Figure 68: Infectious Immunology, Mexico, Company Share (%), 2009 127
Figure 69: Microbiology Culture, Market Segmentation 129
Figure 70: Microbiology Culture Market, Mexico, Revenue Mix ($m), 2009 130
Figure 71: Microbiology Culture Market, Mexico, Category Contribution (%), 2009 131
Figure 72: Microbiology Culture, Mexico, Revenue ($m) by Segment, Historic, 2002-2009 132
Figure 73: Microbiology Culture, Mexico, Revenue ($m) by Segment, Forecast, 2009-2016 134
Figure 74: Microbiology Analyzers, Mexico, Revenue ($m) by Sub-Segment, Historic, 2002-2009 136
Figure 75: Microbiology Analyzers, Mexico, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 138
Figure 76: Microbiology Culture, Mexico, Company Share (%), 2009 141
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),Mexico In Vitro Diagnostics Market, 2009 142
Figure 78: Abbott Laboratories, Company Share (%),Mexico In Vitro Diagnostics Market, 2009 143
Figure 79: Siemens Healthcare, Company Share (%),Mexico In Vitro Diagnostics Market, 2009 144
Figure 80: Beckman Coulter, Inc., Company Share (%),Mexico In Vitro Diagnostics Market, 2009 145
Figure 81: bioMerieux S.A., Company Share (%),Mexico In Vitro Diagnostics Market, 2009 146
Figure 82: Ortho-Clinical Diagnostics Inc., Company Share (%),Mexico In Vitro Diagnostics Market, 2009 147
Figure 83: GlobalData Methodology 176

Browse all Medical Devices Market Research Reports

Browse all GlobalData Market Research Reports

Browse all Newly Published Market Research Reports

Related Reports:

Mexico Diagnostic Imaging Market Outlook to 2016

Japan In Vitro Diagnostics Market Outlook to 2016

India In Vitro Diagnostics Market Outlook to 2016

 

About Us:

Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

 

Contact:

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

Website: http://www.reportsandreports.com/

Blog: http://reportsnreports.wordpress.com/

Blog: http://reportsandreports.blogspot.com/

Customer comments

No comments were found for Mexico In Vitro Diagnostics Market Outlook to 2016 now available at ReportsandReports. Be the first to comment!